Heparin-induced thrombocytopenia in hemodialysis patients.
Brouwer
D J
DJ
In-Line Diagnostics, Farmington, UT, USA.
Peterson
P
P
D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use; D001835:Body Weight; D002809:Chondroitin Sulfates / Q000627:therapeutic use; D000075202:Contraindications; D003871:Dermatan Sulfate / Q000627:therapeutic use; D016903:Drug Monitoring; D006493:Heparin / Q000009:adverse effects*; D006497:Heparan Sulfate / Q000627:therapeutic use; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy; D006435:Renal Dialysis / Q000379:methods; D013921:Thrombocytopenia / Q000139:chemically induced / Q000517:prevention & control
D000925:Anticoagulants; D002809:Chondroitin Sulfates; D003871:Dermatan Sulfate; D006493:Heparin; D006497:Heparan Sulfate; C035838:danaparoid